Comparison of preferences for end-of-life care among patients with advanced cancer and their caregivers: A discrete choice experiment

Palliative Medicine

Volumn 29, Issue 9, 2015, Pages 842-850

  Malhotra, Chetna ^a   Farooqui, Muhammad Assad ^a   Kanesvaran, Ravindran ^b   Bilger, Marcel ^a   Finkelstein, Eric ^a,c  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

choice behavior; decision making; discrete choice experiment; palliative care; Terminal care; willingness to pay

Indexed keywords

ADULT; ADVANCED CANCER; ANALGESIA; ARTICLE; CANCER PAIN; CANCER STAGING; CAREGIVER; CAREGIVER BURDEN; CROSS-SECTIONAL STUDY; DYING; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE FINANCING; HEALTH CARE QUALITY; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; PAIN SEVERITY; PATIENT DECISION MAKING; PATIENT PREFERENCE; QUANTITATIVE ANALYSIS; TERMINAL CARE; AGED; ECONOMICS; FINANCIAL MANAGEMENT; MIDDLE AGED; NEOPLASMS; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; CAREGIVERS; CROSS-SECTIONAL STUDIES; FEMALE; FINANCING, PERSONAL; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAIN MANAGEMENT; PATIENT PREFERENCE; TERMINAL CARE;

EID: 84941947497     PISSN: 02692163     EISSN: 1477030X     Source Type: Journal    
DOI: 10.1177/0269216315578803     Document Type: Article

References (66)

1. Mathers CD, Loncar D,. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3 (11): e442.
2. Wilson DM, Cohen J, Deliens L, et al. The preferred place of last days: results of a representative population-based public survey. J Palliat Med 2013; 16 (5): 502-508.
3. Hunt KJ, Shlomo N, Addington-Hall J,. End-of-life care and achieving preferences for place of death in England: results of a population-based survey using the VOICES-SF questionnaire. Palliat Med 2014; 28 (5): 412-421.
4. Gomes B, Higginson IJ, Calanzani N, et al. Preferences for place of death if faced with advanced cancer: a population survey in England, Flanders, Germany, Italy, the Netherlands, Portugal and Spain. Ann Oncol 2012; 23 (8): 2006-2015.
5. Escobar Pinzon LC, Claus M, Zepf KI, et al. Preference for place of death in Germany. J Palliat Med 2011; 14 (10): 1097-1103.
6. Fukui S, Yoshiuchi K, Fujita J, et al. Japanese peoples preference for place of end-of-life care and death: a population-based nationwide survey. J Pain Symptom Manage 2011; 42 (6): 882-892.
7. Neergaard MA, Jensen AB, Sondergaard J, et al. Preference for place-of-death among terminally ill cancer patients in Denmark. Scand J Caring Sci 2011; 25 (4): 627-636.
8. Maida V, Peck J, Ennis M, et al. Preferences for active and aggressive intervention among patients with advanced cancer. BMC Cancer 2010; 10: 592.
9. Silveira MJ, Kim SY, Langa KM., Advance directives and outcomes of surrogate decision making before death. N Engl J Med 2010; 362 (13): 1211-1218.
10. Shah KK, Tsuchiya A, Wailoo AJ., Valuing health at the end of life: an empirical study of public preferences. Eur J Health Econ. 2014; 15 (4): 389-399.
11. Bischoff KE, Sudore R, Miao Y, et al. Advance care planning and the quality of end-of-life care in older adults. J Am Geriatr Soc 2013; 61 (2): 209-214.
12. Chan HY, Pang SM., Quality of life concerns and end-of-life care preferences of aged persons in long-term care facilities. J Clin Nurs 2007; 16 (11): 2158-2166.
13. Kraai IH, Vermeulen KM, Luttik ML, et al. Preferences of heart failure patients in daily clinical practice: quality of life or longevity? Eur J Heart Fail 2013; 15 (10): 1113-1121.
14. Shmueli A., Survival vs., quality of life: a study of the Israeli public priorities in medical care. Soc Sci Med 1999; 49 (3): 297-302.
15. Solomon MJ, Pager CK, Keshava A, et al. What do patients want? Patient preferences and surrogate decision making in the treatment of colorectal cancer. Dis Colon Rectum 2003; 46 (10): 1351-1357.
16. Kim MK, Lee JL, Hyun MS, et al. Palliative chemotherapy preferences and factors that influence patient choice in incurable advanced cancer. Jpn J Clin Oncol 2008; 38 (1): 64-70.
17. Back MF, Huak CY., Family centred decision making and non-disclosure of diagnosis in a South East Asian oncology practice. Psychooncology 2005; 14 (12): 1052-1059.
18. Elwyn TS, Fetters MD, Gorenflo W, et al. Cancer disclosure in Japan: historical comparisons, current practices. Soc Sci Med 1998; 46 (9): 1151-1163.
19. Miura Y, Asai A, Matsushima M, et al. Families and physicians predictions of dialysis patients preferences regarding life-sustaining treatments in Japan. Am J Kidney Dis 2006; 47 (1): 122-130.
20. Yun YH, You CH, Lee JS, et al. Understanding disparities in aggressive care preferences between patients with terminal illness and their family members. J Pain Symptom Manage 2006; 31 (6): 513-521.
21. Chen WT, Wang SJ, Lu SR, et al. Which level of care is preferred for end-stage dementia? Survey of Taiwanese caregivers. J Geriatr Psychiatry Neurol 2002; 15 (1): 16-19.
22. Suhl J, Simons P, Reedy T, et al. Myth of substituted judgment: surrogate decision making regarding life support is unreliable. Arch Intern Med 1994; 154 (1): 90-96.
23. Sulmasy DP, Terry PB, Weisman CS, et al. The accuracy of substituted judgments in patients with terminal diagnoses. Ann Intern Med 1998; 128 (8): 621-629.
24. Tang ST, Liu TW, Lai MS, et al. Concordance of preferences for end-of-life care between terminally ill cancer patients and their family caregivers in Taiwan. J Pain Symptom Manage 2005; 30 (6): 510-518.
25. Philipson T, Becker G, Goldman D, et al. Terminal care and the value of life near its end. NBER Working Paper Series 15649, 2010. Cambridge, MA: The National Bureau of Economic Research.
26. Malhotra C, Chan A, Do YK, et al. Good end-of-life care: perspectives of middle-aged and older Singaporeans. J Pain Symptom Manage 2012; 44 (2): 252-263.
27. Steinhauser KE, Christakis NA, Clipp EC, et al. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA 2000; 284 (19): 2476-2482.
28. Steinhauser KE, Clipp EC, McNeilly M, et al. In search of a good death: observations of patients, families, and providers. Ann Intern Med 2000; 132 (10): 825-832.
29. Singer PA, Martin DK, Kelner M., Quality end-of-life care: patients perspectives. JAMA 1999; 281 (2): 163-168.
30. Orme BK,. Getting started with conjoint analysis, 2nd ed. Madison, WI: Research Publishers, LLC, 2010.
31. Ryan M., Discrete choice experiments in health care. BMJ 2004; 328 (7436): 360-361.
32. Ryan M, Farrar S., Using conjoint analysis to elicit preferences for health care. BMJ 2000; 320 (7248): 1530-1533.
33. Osoba D, Hsu MA, Copley-Merriman C, et al. Stated preferences of patients with cancer for health-related quality-of-life (HRQOL) domains during treatment. Qual Life Res 2006; 15 (2): 273-283.
34. Chuck A, Adamowicz W, Jacobs P, et al. The willingness to pay for reducing pain and pain-related disability. Value Health 2009; 12 (4): 498-506.
35. Douglas HR, Normand CE, Higginson IJ, et al. A new approach to eliciting patients preferences for palliative day care: the choice experiment method. J Pain Symptom Manage 2005; 29 (5): 435-445.
36. Chu LW, So JC, Wong LC, et al. Community end-of-life care among Chinese older adults living in nursing homes. Geriatr Gerontol Int 2014; 14 (2): 273-284.
37. Whitty JA, Stewart S, Carrington MJ, et al. Patient preferences and willingness-to-pay for a home or clinic based program of chronic heart failure management: findings from the Which? Trial. PLoS ONE 2013; 8 (3): e58347.
38. Nieboer AP, Koolman X, Stolk EA,. Preferences for long-term care services: willingness to pay estimates derived from a discrete choice experiment. Soc Sci Med 2010; 70 (9): 1317-1325.
39. Hall J, Kenny P, Hossain I, et al. Providing informal care in terminal illness: an analysis of preferences for support using a discrete choice experiment. Med Decis Making 2013; 34: 731-745.
40. Muhlbacher AC, Lincke HJ, Nubling M,. Evaluating patients preferences for multiple myeloma therapy, a Discrete-Choice-Experiment. Psychosoc Med 2008; 5: Doc10.
41. Muhlbacher AC, Nubling M,. Analysis of physicians perspectives versus patients preferences: direct assessment and discrete choice experiments in the therapy of multiple myeloma. Eur J Health Econ 2011; 12 (3): 193-203.
42. Central Provident Fund Board. Understanding Medisave and Medishield., 2013, http://mycpf.cpf.gov.sg/CPF/my-cpf/Healthcare/PvdHC3.htm (. accessed 29 April 2013).
43. World Health Organization. Global Health Observatory Data Repository., http://apps.who.int/gho/data/view.country.17900 (2011,. accessed 29 April 2013).
44. Chee SK,. National Cancer Centre Singapore., http://www.nccs.com.sg/AboutUs/DirectorMessage/Pages/Home.aspx (2012,. accessed 4 October 2013).
45. Kao YH, Goh CR,. The practice of nondisclosure of advanced cancer diagnosis in Singapore: a continuing challenge. Singapore Med J 2013; 54 (5): 255-258.
46. Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health-a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health 2011; 14 (4): 403-413.
47. Zwerina K, Huber J, Kuhfeld WF,. A general method for constructing efficient choice designs. Durham, NC: Fuqua School of Business, Duke University, 1996.
48. Hensher D, Greene W,. The Mixed Logit model: the state of practice. Transportation 2003; 30 (2): 133-176.
49. Krinsky I, Robb AL,. On approximating the statistical properties of elasticities. Rev Econ Stat 1986; 68: 715-719.
50. Hole AR,. A comparison of approaches to estimating confidence intervals for willingness to pay measures. Health Econ 2007; 16 (8): 827-840.
51. Landis JR, Koch GG,. The measurement of observer agreement for categorical data. Biometrics 1977; 33 (1): 159-174.
52. Van den Beuken-Van Everdingen M, De Rijke J, Kessels A, et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007; 18 (9): 1437-1449.
53. Tay WK, Shaw RJ, Goh CR,. A survey of symptoms in hospice patients in Singapore. Ann Acad Med Singapore 1994; 23 (2): 191-196.
54. Hong CY, Chow KY, Poulose J, et al. Place of death and its determinants for patients with cancer in Singapore: an analysis of data from the Singapore Cancer Registry, 2000-2009. J Palliat Med 2011; 14 (10): 1128-1134.
55. Gao W, Ho YK, Verne J, et al. Changing patterns in place of cancer death in England: a population-based study. PLoS Med 2013; 10 (3): e1001410.
56. Higginson IJ, Astin P, Imperial SD,. Where do cancer patients die? Ten-year trends in the place of death of cancer patients in England. Palliat Med 1998; 12 (5): 353-363.
57. Gomes B, Higginson IJ,. Home or hospital? Choices at the end of life. J R Soc Med 2004; 97 (9): 413-414.
58. Tang ST, Huang EW, Liu TW, et al. Propensity for home death among Taiwanese cancer decedents in 2001-2006, determined by services received at end of life. J Pain Symptom Manage 2010; 40 (4): 566-574.
59. Ostbye T, Malhotra R, Malhotra C, et al. Does support from foreign domestic workers decrease the negative impact of informal caregiving? Results from Singapore survey on informal caregiving. J Gerontol B Psychol Sci Soc Sci 2013; 68 (4): 609-621.
60. National Institute for Health and Care Excellence. Measuring effectiveness and cost effectiveness: QALY., http://www.nice.org.uk/newsroom/features/measuringeffectivenessandcosteffectivenesstheqaly.jsp (2010,. accessed 9 April 2013).
61. Grosse SD,. Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold. Expert Rev Pharmacoecon Outcomes Res 2008; 8 (2): 165-178.
62. McCabe C, Claxton K, Culyer AJ,. The NICE cost-effectiveness threshold: what it is and what that means. Pharmacoeconomics 2008; 26 (9): 733-744.
63. The World Bank. World Development Indicators., http://data.worldbank.org/ (2012,. accessed 17 February 2014).
64. Eichler H-G, Kong SX, Gerth WC, et al. Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? Value Health 2004; 7 (5): 518-528.
65. Telser H, Zweifel P,. Validity of discrete-choice experiments evidence for health risk reduction. Appl Econ 2007; 39 (1): 69-78.
66. Mark TL, Swait J,. Using stated preference and revealed preference modeling to evaluate prescribing decisions. Health Econ 2004; 13 (6): 563-573.